文献速递类风湿关节炎

类风湿关节炎女性辅助生殖后活产几率降低:全国队列研究

Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study.
PubMed 文献 · Ann Rheum Dis · 2019-01-12

基于丹麦全国登记数据,比较类风湿关节炎女性与非类风湿关节炎女性在辅助生殖技术(ART)治疗后的活产几率。

要点

  • 类风湿关节炎女性ART后每次胚胎移植活产几率显著低于无类风湿关节炎女性(aOR 0.78)。
  • 生化妊娠几率亦降低(aOR 0.81),临床妊娠几率差异无统计学意义。
  • 胚胎移植前使用糖皮质激素与活产几率的关系需进一步研究。

核心结论

  • 类风湿关节炎女性接受ART治疗后活产几率较无类风湿关节炎女性显著降低,结果提示问题与胚胎着床几率受损有关。
  • 胚胎移植前使用糖皮质激素的作用需进一步研究。

研究设计与样本

  • 基于丹麦全国健康登记处的队列研究,纳入1994年1月1日至2017年6月30日期间所有进行胚胎移植的女性。

主要发现

  • 类风湿关节炎女性相对无类风湿关节炎女性,每次胚胎移植活产的调整OR为0.78(95%CI 0.65-0.92)。
  • 生化妊娠的调整OR为0.81(95%CI 0.68-0.95),临床妊娠的调整OR为0.82(95%CI 0.59-1.15)。
  • 胚胎移植前开具糖皮质激素处方的活产OR为1.32(95%CI 0.85-2.05)。

临床怎么用

  • 对接受ART的类风湿关节炎女性,应告知其活产几率可能低于无类风湿关节炎女性。
  • 胚胎移植前糖皮质激素使用的获益与风险需个体化评估,并作为进一步研究议题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: No studies have examined the efficacy of assisted reproductive technology (ART) treatment in women with rheumatoid arthritis. Therefore, we examined the chance of live birth after ART treatment in women with rheumatoid arthritis compared with women without rheumatoid arthritis. METHODS: Our cohort study is based on nationwide Danish health registries, comprising all women with an embryo transfer during 1 January 1994 through 30 June 2017. The cohorts comprised 1149 embryo transfers in women with rheumatoid arthritis, and 198 941 embryo transfers in women without rheumatoid arthritis. Our outcome was live birth per embryo transfer, and we controlled for multiple covariates in the analyses. In subanalyses, we examined a chance of biochemical/clinical pregnancy after ART and a possible impact of corticosteroid use prior to embryo transfer. RESULTS: The adjusted OR (aOR) for a live birth per embryo transfer in women with rheumatoid arthritis, relative to women without rheumatoid arthritis, was 0.78 (95% CI 0.65 to 0.92). The aORs for biochemical and clinical pregnancies were 0.81 (95% CI 0.68 to 0.95) and 0.82 (95% CI 0.59 to 1.15), respectively. Corticosteroid prescription prior to embryo transfer increased the OR for live birth (aOR=1.32 (95% CI 0.85 to 2.05)). CONCLUSIONS: The chance of a live birth was significantly reduced in women with rheumatoid arthritis receiving ART treatment, relative to women without rheumatoid arthritis, and our result suggested that the problem was related to an impaired chance of embryo implantation. The role of corticosteroid use prior to embryo transfer must be a subject for further research.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Nørgård BM, Larsen MD, Friedman S, et al. Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study. Ann Rheum Dis. 2019. PMID: 30636215. doi:10.1136/annrheumdis-2018-214619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。